Citadel Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.56M Buy
32,100
+19,100
+147% +$5.17M ﹤0.01% 3469
2025
Q4
$3.26M Buy
13,000
+800
+7% +$212K ﹤0.01% 5014
2025
Q3
$3.5M Sell
12,200
-17,400
-59% -$4.66M ﹤0.01% 5008
2025
Q2
$7.77M Buy
29,600
+20,600
+229% +$5.02M ﹤0.01% 3400
2025
Q1
$2.09M Sell
9,000
-5,100
-36% -$1.24M ﹤0.01% 5452
2024
Q4
$3.23M Sell
14,100
-35,300
-71% -$8.1M ﹤0.01% 4713
2024
Q3
$11M Sell
49,400
-24,100
-33% -$5.3M ﹤0.01% 2748
2024
Q2
$15M Buy
73,500
+34,600
+89% +$7.04M ﹤0.01% 2318
2024
Q1
$8.5M Sell
38,900
-29,300
-43% -$6.45M ﹤0.01% 3146
2023
Q4
$15.5M Sell
68,200
-139,600
-67% -$29.3M ﹤0.01% 2296
2023
Q3
$41.8M Sell
207,800
-54,216
-21% -$11.4M 0.01% 1221
2023
Q2
$54.3M Sell
262,016
-41,206
-14% -$7.99M 0.01% 986
2023
Q1
$59.8M Sell
303,222
-121,172
-29% -$24.9M 0.01% 938
2022
Q4
$85.9M Buy
424,394
+294,841
+228% +$57.6M 0.02% 729
2022
Q3
$22.8M Buy
129,553
+54,009
+71% +$11.1M 0.01% 1751
2022
Q2
$15.2M Sell
75,544
-88,231
-54% -$18.8M ﹤0.01% 2151
2022
Q1
$37.1M Buy
163,775
+117,448
+254% +$27.6M 0.01% 1352
2021
Q4
$12.5M Sell
46,327
-33,989
-42% -$8.41M ﹤0.01% 2693
2021
Q3
$19.4M Sell
80,316
-22,232
-22% -$5.6M ﹤0.01% 2034
2021
Q2
$24.3M Buy
102,548
+19,555
+24% +$4.46M 0.01% 1850
2021
Q1
$18.2M Sell
82,993
-8,381
-9% -$1.68M ﹤0.01% 2092
2020
Q4
$16M Buy
91,374
+18,624
+26% +$3.22M ﹤0.01% 2056
2020
Q3
$11.8M Sell
72,750
-18,275
-20% -$2.9M ﹤0.01% 2096
2020
Q2
$13M Buy
91,025
+7,450
+9% +$1.03M ﹤0.01% 1939
2020
Q1
$9.07M Buy
83,575
+38,994
+87% +$5.62M ﹤0.01% 1962
2019
Q4
$6.48M Sell
44,581
-6,519
-13% -$941K ﹤0.01% 2752
2019
Q3
$7.38M Sell
51,100
-1,047
-2% -$153K ﹤0.01% 2595
2019
Q2
$7.75M Sell
52,147
-9,894
-16% -$1.38M ﹤0.01% 2502
2019
Q1
$8.15M Buy
62,041
+24,444
+65% +$3.01M ﹤0.01% 2316
2018
Q4
$4.08M Buy
37,597
+2,444
+7% +$327K ﹤0.01% 3068
2018
Q3
$5.25M Sell
35,153
-6,751
-16% -$1.03M ﹤0.01% 2947
2018
Q2
$6.46M Buy
41,904
+13,735
+49% +$2.07M ﹤0.01% 2436
2018
Q1
$3.91M Buy
28,169
+7,217
+34% +$1.06M ﹤0.01% 2758
2017
Q4
$2.87M Sell
20,952
-4,889
-19% -$646K ﹤0.01% 3153
2017
Q3
$3.35M Buy
25,841
+2,445
+10% +$326K ﹤0.01% 2761
2017
Q2
$3.1M Sell
23,396
-10,360
-31% -$1.27M ﹤0.01% 2624
2017
Q1
$4.16M Sell
33,756
-25,259
-43% -$2.99M ﹤0.01% 2232
2016
Q4
$6.51M Sell
59,015
-2,328
-4% -$259K 0.01% 1724
2016
Q3
$7.25M Buy
61,343
+37,830
+161% +$4.46M 0.01% 1642
2016
Q2
$2.63M Sell
23,513
-21,883
-48% -$2.36M ﹤0.01% 2445
2016
Q1
$4.57M Buy
45,396
+32,010
+239% +$3.07M 0.01% 1857
2015
Q4
$1.42M Sell
13,386
-1,048
-7% -$108K ﹤0.01% 3157
2015
Q3
$1.34M Sell
14,434
-2,211
-13% -$229K ﹤0.01% 3427
2015
Q2
$1.73M Sell
16,645
-4,423
-21% -$460K ﹤0.01% 3222
2015
Q1
$2.28M Buy
21,068
+6,052
+40% +$622K ﹤0.01% 2902
2014
Q4
$1.39M Sell
15,016
-3,724
-20% -$329K ﹤0.01% 3350
2014
Q3
$1.64M Sell
18,740
-3,842
-17% -$347K ﹤0.01% 3091
2014
Q2
$1.99M Buy
22,582
+12,455
+123% +$1.08M ﹤0.01% 2736
2014
Q1
$854K Sell
10,127
-11,291
-53% -$900K ﹤0.01% 3633
2013
Q4
$1.68M Buy
21,418
+5,471
+34% +$467K ﹤0.01% 2718
2013
Q3
$1.36M Sell
15,947
-4,539
-22% -$382K ﹤0.01% 2788
2013
Q2
$1.76M Buy
+20,486
New +$1.7M ﹤0.01% 2624

Other funds holding LH

Citadel Advisors's LH Position: Q1 2026 in Review

Citadel Advisors reduced its Labcorp (LH) stake by 52% in Q1 2026, selling an estimated $20.8M and leaving 71,339 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Citadel Advisors first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $328M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Citadel Advisors held 71,339 shares of Labcorp worth $19M as of Q1 2026.
  • Citadel Advisors sold 76,957 Labcorp shares in Q1 2026, an estimated $20.8M.
  • Labcorp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2393 holding.
  • Citadel Advisors first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
  • Citadel Advisors's Labcorp position peaked at $328M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.